Apellis Pharmaceuticals is a biotechnology research company developing drug delivery technologies and therapeutics for the treatment of chronic inflammatory diseases.
| CAGE Code | 5XS18 |
|---|---|
| Legal Name | Apellis Pharmaceuticals, Inc. |
| Company Operating Status | Active |
| Full Address | 100 Fifth Ave, 3rd Floor, Waltham, MA 02451, US |
| Public/Private | Public |
| Stock Symbol | APLS |
| Ticker Symbol | APLS |
| Wellfound ID | apellis-pharmaceuticals |